Literature DB >> 17300362

Female sex hormones and rat dural vasodilatation to CGRP, periarterial electrical stimulation and capsaicin.

Saurabh Gupta1, Carlos M Villalón, Suneet Mehrotra, René de Vries, Ingrid M Garrelds, Pramod R Saxena, Antoinette MaassenVanDenbrink.   

Abstract

BACKGROUND: The prevalence of migraine is 2 to 3-fold higher in females than in males, and it is intricately related to the levels of female sex hormones. These hormones may regulate the synthesis and receptor expression of calcitonin gene-related peptide (CGRP), which mediates neurogenic dural vasodilatation and is implicated in migraine pathogenesis.
OBJECTIVE: To investigate the effects of the female sex steroids, 17beta-estradiol and progesterone, separately and in combination, on dural vasodilatation induced by alphaCGRP, periarterial electrical stimulation and capsaicin in ovariectomized rats, using intravital microscopy.
METHODS: Sprague-Dawley rats were ovariectomized and, 7 days later, subcutaneously implanted with 21-day release pellets of 17beta-estradiol, progesterone, their combination or placebo. On day 19 to 21, the animals were anesthetized, overlying bone thinned to visualize the middle meningeal artery and vasodilator responses to alphaCGRP (10 to 3000 ng kg(-1)), periarterial electrical stimulation (25 to 125 microA) and capsaicin (0.3 to 18 microg kg(-1)) elicited.
RESULTS: There were no significant differences in the vasodilator potency or efficacy of alphaCGRP or capsaicin in the different groups studied. In contrast, the vasodilator response to electrical stimulation was significantly higher in rats treated with 17beta-estradiol (Emax:157 +/- 19%) as compared to those observed after placebo treatment (Emax:93 +/- 11%).
CONCLUSION: Our results show that, in contrast to CGRP- or capsaicin-induced dural vasodilatation, 17beta-estradiol enhanced neurogenic vasodilatation, suggesting increased CGRP release from perivascular nerves. This may be one of the mechanisms through which 17beta-estradiol exacerbates migraine in women.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17300362     DOI: 10.1111/j.1526-4610.2006.00526.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  15 in total

1.  Dural Calcitonin Gene-Related Peptide Produces Female-Specific Responses in Rodent Migraine Models.

Authors:  Amanda Avona; Carolina Burgos-Vega; Michael D Burton; Armen N Akopian; Theodore J Price; Gregory Dussor
Journal:  J Neurosci       Date:  2019-04-08       Impact factor: 6.167

Review 2.  Menstrual migraine: what it is and does it matter?

Authors:  Letizia Maria Cupini; Ilenia Corbelli; Paola Sarchelli
Journal:  J Neurol       Date:  2020-01-28       Impact factor: 4.849

3.  Behavioral effects and mechanisms of migraine pathogenesis following estradiol exposure in a multibehavioral model of migraine in rat.

Authors:  Lydia M M Vermeer; Eugene Gregory; Michelle K Winter; Kenneth E McCarson; Nancy E J Berman
Journal:  Exp Neurol       Date:  2014-09-28       Impact factor: 5.330

4.  Effects of ionotropic glutamate receptor antagonists on rat dural artery diameter in an intravital microscopy model.

Authors:  K Y Chan; S Gupta; R de Vries; A H J Danser; C M Villalón; E Muñoz-Islas; A Maassenvandenbrink
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

Review 5.  Targeting BKCa Channels in Migraine: Rationale and Perspectives.

Authors:  Mohammad Al-Mahdi Al-Karagholi; Christian Gram; Cherie Amalie Waldorff Nielsen; Messoud Ashina
Journal:  CNS Drugs       Date:  2020-04       Impact factor: 5.749

Review 6.  Sex and the migraine brain.

Authors:  D Borsook; N Erpelding; A Lebel; C Linnman; R Veggeberg; P E Grant; C Buettner; L Becerra; R Burstein
Journal:  Neurobiol Dis       Date:  2014-03-21       Impact factor: 5.996

7.  Methylation of migraine-related genes in different tissues of the rat.

Authors:  Sieneke Labruijere; Lisette Stolk; Michael Verbiest; René de Vries; Ingrid M Garrelds; Paul H C Eilers; A H Jan Danser; André G Uitterlinden; Antoinette MaassenVanDenBrink
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

Review 8.  Heteroreceptors Modulating CGRP Release at Neurovascular Junction: Potential Therapeutic Implications on Some Vascular-Related Diseases.

Authors:  Abimael González-Hernández; Bruno A Marichal-Cancino; Jair Lozano-Cuenca; Jorge S López-Canales; Enriqueta Muñoz-Islas; Martha B Ramírez-Rosas; Carlos M Villalón
Journal:  Biomed Res Int       Date:  2016-12-27       Impact factor: 3.411

Review 9.  Gender aspects of CGRP in migraine.

Authors:  Alejandro Labastida-Ramírez; Eloísa Rubio-Beltrán; Carlos M Villalón; Antoinette MaassenVanDenBrink
Journal:  Cephalalgia       Date:  2017-10-30       Impact factor: 6.292

10.  Effects of two isometheptene enantiomers in isolated human blood vessels and rat middle meningeal artery - potential antimigraine efficacy.

Authors:  Alejandro Labastida-Ramírez; Eloísa Rubio-Beltrán; Kristian A Haanes; René de Vries; Ruben Dammers; A J J C Bogers; Antoon van den Bogaerdt; Bruce L Daugherty; Alexander H J Danser; Carlos M Villalón; Antoinette MaassenVanDenBrink
Journal:  J Headache Pain       Date:  2019-05-03       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.